Jakob Dupont, SVP & Chief Medical Officer at OncoMed Pharmaceuticals Inc (OMED), sold 5,000 shares at $20.00 ($100K) on 2015-10-26, disclosed to the SEC on 2015-10-27.
Scheduled sale ($100k) by SVP & Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ATRA | SELL | 2022-11-18 | $19K | — | Filing → |
| ATRA | SELL | 2022-08-18 | $21K | — | Filing → |
| ATRA | SELL | 2022-05-19 | $21K | — | Filing → |